Venetoclax plus dose-adjusted R-EPOCH for Richter syndromeMatthew S. Davids, Jennifer R. Brown, Samantha Pazienza et al.|Blood|2021Cited by 75
A multicenter phase II study of venetoclax plus dose-adjusted R-EPOCH (VR-EPOCH) for Richter’s syndrome.Matthew S. Davids, Philip A. Thompson, Kerry A. Rogers et al.|Journal of Clinical Oncology|2020Cited by 12